Esther (Seung-Yun) Yoo, Ph.D., is the Head of Development Sales at Samsung Biologics, where she leads the CDO, Small Plant (1 KL), and Platform Sales for mRNA. She has a breadth and depth of commercial experience in global and U.S. markets. Prior to joining Samsung Biologics, Esther held various roles at Gilead Sciences in Marketing, Strategic Pricing and Market Access Analytics, and Market Research. Esther received her Ph.D. in neuroscience at Baylor College of Medicine, followed by a postdoctoral fellowship at Harvard Medical School, where she was a recipient of the Autism Speaks Postdoctoral Fellowship Grant.
.svg)
